Skip to main content
      Getting more data on using deucravacitinib for PsO/PsA manifestations
      Impressive effect on scalp psoriasis (which often

      David Liew drdavidliew

      9 months 3 weeks ago
      Getting more data on using deucravacitinib for PsO/PsA manifestations Impressive effect on scalp psoriasis (which often means a lot to patients) Given how safe it is, it's increasingly tempting to use more of it in mild-mod PsA #ACR24 PSORIATYK SCALP trial ABST1137 @RheumNow https://t.co/vxS3RSlIN0
      Cowley et al. US pattern in Subclinical GCA in PMR vs GCA. Subclinical GCA has more isolated axillary artery involvemen

      Richard Conway RichardPAConway

      9 months 3 weeks ago
      Cowley et al. US pattern in Subclinical GCA in PMR vs GCA. Subclinical GCA has more isolated axillary artery involvement. Severity of US inflammation significantly higher in GCA than subclincal GCA @RheumNow #ACR24 Abstr#1629 https://t.co/6Iyx76YgkS https://t.co/DxzTEwE5J5
      Abst #1473 evaluated association of SJC in PROs from 2 Bimekizumab trials (bDMARD naïve vs TNFi-IR)

      -bDMARD naïve ha

      Adela Castro AdelaCastro222

      9 months 3 weeks ago
      Abst #1473 evaluated association of SJC in PROs from 2 Bimekizumab trials (bDMARD naïve vs TNFi-IR) -bDMARD naïve had less SJC at baseline -In both groups, pts w lower SJC had sustained improvement in pain and fatigue over time. #ACR24 @RheumNow https://t.co/zwxsSbga7c
      Findings from Abstr#1436 reveal that cigarette smoking is not positively associated with radiographic progression in pso

      Antoni Chan MD (Prof) synovialjoints

      9 months 3 weeks ago
      Findings from Abstr#1436 reveal that cigarette smoking is not positively associated with radiographic progression in psoriatic arthritis (PsA). Current and past smokers showed a longer time to joint damage progression. This suggests a complex relationship that warrants further… https://t.co/ERsAKoivA4
      What do current national/international rheumatology association guidelines say about perioperative discontinuation of bi

      David Liew drdavidliew

      9 months 3 weeks ago
      What do current national/international rheumatology association guidelines say about perioperative discontinuation of biologics? it's highly, highly variable no wonder people get confused! #ACR24 ABST1037 @CatherineL_Hill @RheumNow https://t.co/cmJ3qKU1QT
      Serrano-Combarro et al. Case series of upadacitinib in RA-ILD. 18 patients. Report stable/improved dyspnoea and HRCT ove

      Richard Conway RichardPAConway

      9 months 3 weeks ago
      Serrano-Combarro et al. Case series of upadacitinib in RA-ILD. 18 patients. Report stable/improved dyspnoea and HRCT over 12 months. PFTs shown, relatively stable @RheumNow #ACR24 Abstr#1372 https://t.co/yncy0lPq60 https://t.co/mrDMtEDwUt
      Great table re:side effects of even low dose steroids in RA

      Likely generalizes to other diseases ie PMR, SLE

      P in pred

      Mike Putman EBRheum

      9 months 3 weeks ago
      Great table re:side effects of even low dose steroids in RA Likely generalizes to other diseases ie PMR, SLE P in prednisone stands for poison! #ACR24 @RheumNow https://t.co/0opDEtzm9E
      How do we prevent SLE flares requiring steroids?

      Petri:
      Background medication!
      HCQ adherence is key
      -check WB levels t

      Eric Dein ericdeinmd

      9 months 3 weeks ago
      How do we prevent SLE flares requiring steroids? Petri: Background medication! HCQ adherence is key -check WB levels to measure EULAR recs early addition of immunosuppress/biols “Taper quickly, withdraw slowly” Come down quick, then slowly off @RheumNow #ACR24 @jhrheumatology
      Are biosimilar multi-switches an issue?

      real world data: DANBIO 🇩🇰
      biosimilar to biosimilar switch
      having already

      David Liew drdavidliew

      9 months 3 weeks ago
      Are biosimilar multi-switches an issue? real world data: DANBIO 🇩🇰 biosimilar to biosimilar switch having already had a switch prior ('previous ADAo') did not increase cessation The risk of biosimilar switching on immunogenicity is greatly overstated #ACR24 ABST1000 @RheumNow https://t.co/1yAfZrrNd0
      #1156

      @DidemSayginMD et al finds that ~1/3 patients with myositis have comorbid fibromyalgia

      ➡️Presence of fibrom

      Caoilfhionn Connolly CaoilfhionnMD

      9 months 3 weeks ago
      #1156 @DidemSayginMD et al finds that ~1/3 patients with myositis have comorbid fibromyalgia ➡️Presence of fibromyalgia significantly impacted patient global disease activity #acr24 @RheumNow https://t.co/u1XfqrQU1H
      Late-onset asthma but earlier EGPA diagnosis?

      Abstract 1604 used IQVIA data to develop a machine learning model for be

      Akhil Sood MD AkhilSoodMD

      9 months 3 weeks ago
      Late-onset asthma but earlier EGPA diagnosis? Abstract 1604 used IQVIA data to develop a machine learning model for better EGPA dx. Key predictors included eosinophilia, asthma, chronic sinusitis, multiple CXRs, skin biopsies, and GC prescriptions. @RheumNow #ACR24
      Sukumaran et al. Does does of IA steroid matter in knee injection? RCT 30 patients. Triamcinolone. 6-week WOMAC decrease

      Richard Conway RichardPAConway

      9 months 3 weeks ago
      Sukumaran et al. Does does of IA steroid matter in knee injection? RCT 30 patients. Triamcinolone. 6-week WOMAC decrease 6% in 10mg, 10% in 20mg , 29% in 40mg @RheumNow #ACR24 Abstr#1186 https://t.co/WUYiEP5dSo
      ×